The role of users in innovation in the pharmaceutical industry
Authors:
- Ruud E.H.M. SmitsRSRuud E.H.M. Smits
- Wouter P.C. BoonWBWouter P.C. Boon
- 1 April 2008
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 13 (7-8) , 353-359
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A delicate balancing actNature Reviews Drug Discovery, 2007
- Should patient groups accept money from drug companies? NoBMJ, 2007
- Discussions in Geneva, demonstrations in Delhi: why incentives for drug innovation need reviewingDrug Discovery Today, 2007
- New clinical trials policy at FDANature Biotechnology, 2006
- A long week in stem-cell politics...Nature, 2006
- How NICE may be outflankedBMJ, 2006
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- The rise of systemic instruments in innovation policyInternational Journal of Foresight and Innovation Policy, 2004
- STATUS AND POTENTIAL OF GENE THERAPY IN CLINICAL MEDICINEInternational Journal of Technology Assessment in Health Care, 2002
- The state of the art of the science of drug discovery—an opinionDrug Development Research, 1984